Clinical Trial Update: A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2/3 trial of UX701 gene therapy for Wilson disease is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wilson Disease

Drugs mentioned

• UX701

Snippet

Sponsor: Ultragenyx Pharmaceutical Inc | Conditions: Wilson Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING